[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  PharmaShots - Incisive news in X shots [@Pharmashot](/creator/twitter/Pharmashot) on x 2267 followers Created: 2025-06-26 13:05:47 UTC Galderma Initiates P-II Studies of Nemolizumab for Systemic Sclerosis (SSc) and Chronic Pruritus of Unknown Origin (CPUO) #galderma #nemolizumab #systemicsclerosis #chronicpruritusofunknownorigin #il31 #monoclonalantibody #atopicdermatitis #prurigonodular  XX engagements  **Related Topics** [$galdsw](/topic/$galdsw) [Post Link](https://x.com/Pharmashot/status/1938222158658052211)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
PharmaShots - Incisive news in X shots @Pharmashot on x 2267 followers
Created: 2025-06-26 13:05:47 UTC
Galderma Initiates P-II Studies of Nemolizumab for Systemic Sclerosis (SSc) and Chronic Pruritus of Unknown Origin (CPUO) #galderma #nemolizumab #systemicsclerosis #chronicpruritusofunknownorigin #il31 #monoclonalantibody #atopicdermatitis #prurigonodular
XX engagements
Related Topics $galdsw
/post/tweet::1938222158658052211